APA

Le Berre L., Rousse J., Gourraud P., Imbert-Marcille B., Salama A., Evanno G., Semana G., Nicot A., Dugast E., Guérif P., Adjaoud C., Freour T., Brouard S., Agbalika F., Marignier R., Brassat D., Laplaud D., Drouet E., Van Pesch V. & Soulillou J. (20170829). Decrease of blood anti-α1,3 Galactose Abs levels in multiple sclerosis (MS) and clinically isolated syndrome (CIS) patients. : Clinical immunology (Orlando, Fla.).

Chicago

Le Berre L, Rousse J, Gourraud P-A, Imbert-Marcille B-M, Salama A, Evanno G, Semana G, Nicot A, Dugast E, Guérif P, Adjaoud C, Freour T, Brouard S, Agbalika F, Marignier R, Brassat D, Laplaud D-A, Drouet E, Van Pesch V and Soulillou J-P. 20170829. Decrease of blood anti-α1,3 Galactose Abs levels in multiple sclerosis (MS) and clinically isolated syndrome (CIS) patients. : Clinical immunology (Orlando, Fla.).

Harvard

Le Berre L., Rousse J., Gourraud P., Imbert-Marcille B., Salama A., Evanno G., Semana G., Nicot A., Dugast E., Guérif P., Adjaoud C., Freour T., Brouard S., Agbalika F., Marignier R., Brassat D., Laplaud D., Drouet E., Van Pesch V. and Soulillou J. (20170829). Decrease of blood anti-α1,3 Galactose Abs levels in multiple sclerosis (MS) and clinically isolated syndrome (CIS) patients. : Clinical immunology (Orlando, Fla.).

MLA

Le Berre L, Rousse J, Gourraud P-A, Imbert-Marcille B-M, Salama A, Evanno G, Semana G, Nicot A, Dugast E, Guérif P, Adjaoud C, Freour T, Brouard S, Agbalika F, Marignier R, Brassat D, Laplaud D-A, Drouet E, Van Pesch V and Soulillou J-P. Decrease of blood anti-α1,3 Galactose Abs levels in multiple sclerosis (MS) and clinically isolated syndrome (CIS) patients. : Clinical immunology (Orlando, Fla.). 20170829.